{
  "schemaType": "LegalCase",
  "title": "Roundup / Glyphosate",
  "shortName": "Roundup",
  "slug": "roundup",
  "canonicalUrl": "https://tortsignals.lawtegic.solutions/torts/roundup",
  "description": "Roundup remains active in state courts despite Bayer's $11B settlement program. Pennsylvania state court has emerged as the new venue of choice with multiple plaintiff verdicts. Window for new filings is narrowing.",
  "body": "Roundup remains active in state courts despite Bayer's $11B settlement program. Pennsylvania state court has emerged as the new venue of choice with multiple plaintiff verdicts. Window for new filings is narrowing.",
  "tortSignalScore": 80,
  "opportunityScore": 72,
  "riskScore": 38,
  "mdl": "State courts (PA, MO active)",
  "docket": "State courts (PA, MO active)",
  "drugName": "Roundup",
  "defendant": "Bayer / Monsanto",
  "primaryInjury": "Non-Hodgkin lymphoma (NHL)",
  "jurisdictionLead": "Pennsylvania",
  "stage": "late",
  "campaign": "CLOSING",
  "caseValueRange": "$50K – $250K (post-settlement era)",
  "litigationStatus": "Active state court dockets in PA, MO, CA. Federal MDL largely wound down. Bayer's settlement program continues but accepting fewer new claims.",
  "attorneyAction": "Time-sensitive. Statute of limitations is closing in many jurisdictions. Pennsylvania remains best venue. Document exposure history meticulously.",
  "qualifies": "Individuals with documented Roundup exposure (occupational or residential) who were diagnosed with Non-Hodgkin lymphoma.",
  "competition": "high",
  "recentNews": [
    {
      "date": "Apr 10, 2026",
      "source": "Law360",
      "headline": "Pa. jury awards $78M in latest Roundup NHL verdict"
    },
    {
      "date": "Apr 02, 2026",
      "source": "Reuters",
      "headline": "Bayer narrows Roundup settlement eligibility window"
    }
  ],
  "faq": [
    {
      "q": "What is the Roundup lawsuit about?",
      "a": "Plaintiffs allege exposure to Monsanto's glyphosate-based Roundup herbicide caused Non-Hodgkin lymphoma. The IARC classified glyphosate as a probable human carcinogen in 2015."
    },
    {
      "q": "Who qualifies?",
      "a": "Individuals with documented occupational or residential Roundup exposure who developed Non-Hodgkin lymphoma."
    },
    {
      "q": "What is the case value?",
      "a": "Post-settlement era values typically range from $50,000 to $250,000, though large verdicts in state court continue."
    },
    {
      "q": "What is the current status?",
      "a": "Federal MDL is largely concluded. Active state court litigation continues in Pennsylvania, Missouri, and California with ongoing plaintiff verdicts."
    },
    {
      "q": "What should attorneys do?",
      "a": "Move quickly — statute of limitations is closing in many jurisdictions. Pennsylvania state court remains the most plaintiff-friendly venue."
    }
  ],
  "publisher": {
    "name": "LawTegic Solutions Media",
    "brand": "TortSignal",
    "url": "https://tortsignals.lawtegic.solutions"
  },
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "updatedAt": "2026-06-18T21:13:39.411Z"
}